CACNB2: An emerging pharmacological target for hypertension, heart failure, arrhythmia and mental disorders

Current Molecular Pharmacology

Volumn 8, Issue 1, 2015, Pages 32-42

  Soldatov, Nikolai M ^a  

^a Humgenex Inc   (United States)

Author keywords

Cav1.2 calcium channel; Cav subunits; CACNB2; Heart failure; hypertension; mental disorders

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; CACNB2 INHIBITOR; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL CAV1.2; CALCIUM CHANNEL CAVBETA2; CARDIOVASCULAR AGENT; GUANYLATE KINASE; PROTEIN SH3; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED CALCIUM CHANNEL BETA2CED; VOLTAGE GATED CALCIUM CHANNEL CACNA1C; VOLTAGE GATED CALCIUM CHANNEL CACNB2; CACNB2 PROTEIN, HUMAN; CALCIUM CHANNEL L TYPE;

ANTIARRHYTHMIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CALCIUM CURRENT; CALCIUM SIGNALING; DRUG MECHANISM; DRUG TARGETING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; MENTAL DISEASE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PSYCHOPHARMACOLOGY; REGULATORY MECHANISM; STRUCTURE ACTIVITY RELATION; ARRHYTHMIAS, CARDIAC; DRUG EFFECTS; GENETICS; MENTAL DISORDERS;

ARRHYTHMIAS, CARDIAC; CALCIUM CHANNELS, L-TYPE; HEART FAILURE; HUMANS; HYPERTENSION; MENTAL DISORDERS;

EID: 84942114528     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467208666150507093258     Document Type: Article

References (81)

1. Lloyd-Jones, D.; Adams, R.J.; Brown, T.M.; Carnethon, M.; Dai, S.; De Simone, G.; Ferguson, T.B.; Ford, E.; Furie, K.; Gillespie, C.; Go, A.; Greenlund, K.; Haase, N.; Hailpern, S.; Ho, P.M.; Howard, V.; Kissela, B.; Kittner, S.; Lackland, D.; Lisabeth, L.; Marelli, A.; McDermott, M.M.; Meigs, J.; Mozaffarian, D.; Mussolino, M.; Nichol, G.; Roger, V.; Rosamond, W.; Sacco, R.; Sorlie, P.; Stafford, R.; Thom, T.; Wasserthiel-Smoller, S.; Wong, N.D.; Wylie-Rosett, J.; on behalf of the American Heart Association Statistics Committee and Stroke Statistics, S. Heart disease and stroke statistics -2010 update. A report from the American Heart Association. Circulation, 2010, 121, e1-170.
2. Insel, T.R. Assessing the economic costs of serious mental illness. Am. J. Psychiatry, 2008, 165, 703-711.
3. Adeyemo, A.; Gerry, N.; Chen, G.; Herbert, A.; Doumatey, A.; Huang, H.; Zhou, J.; Lashley, K.; Chen, Y.; Christman, M.; Rotimi, C. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet., 2009, 5, e1000564.
4. Ho, J.E.; Levy, D.; Rose, L.; Johnson, A.D.; Ridker, P.M.; Chasman, D.I. Discovery and replication of novel blood pressure genetic loci in the Women's Genome Health Study. J. Hypertens., 2011, 29, 62-69.
5. Levy, D.; Ehret, G.B.; Rice, K.; Verwoert, G.C.; Launer, L.J.; Dehghan, A.; Glazer, N.L.; Morrison, A.C.; Johnson, A.D.; Aspelund, T.; Aulchenko, Y.; Lumley, T.; Kottgen, A.; Vasan, R.S.; Rivadeneira, F.; Eiriksdottir, G.; Guo, X.; Arking, D.E.; Mitchell, G.F.; Mattace-Raso, F.U.S.; Smith, A.V.; Taylor, K.; Scharpf, R.B.; Hwang, S.-J.; Sijbrands, E.J.G.; Bis, J.; Harris, T.B.; Ganesh, S.K.; O'Donnell, C.J.; Hofman, A.; Rotter, J.I.; Coresh, J.; Benjamin, E.J.; Uitterlinden, A.G.; Heiss, G.; Fox, C.S.; Witteman, J.C.M.; Boerwinkle, E.; Wang, T.J.; Gudnason, V.; Larson, M.G.; Chakravarti, A.; Psaty, B.M.; van Duijn, C.M. Genome-wide association study of blood pressure and hypertension. Nat. Genet., 2009, 41, 677-687.
6. Wain, L.V.; Verwoert, G.C.; O'Reilly, P.F.; Shi, G.; Johnson, T.; Johnson, A.D.; Bochud, M.; Rice, K.M.; Henneman, P.; Smith, A.V.; Ehret, G.B.; Amin, N.; Larson, M.G.; Mooser, V.; Hadley, D.; Dorr, M.; Bis, J.C.; Aspelund, T.; Esko, T.; Janssens, A.C.J.W.; Zhao, J.H.; Heath, S.; Laan, M.; Fu, J.; Pistis, G.; Luan, J.a.; Arora, P.; Lucas, G.; Pirastu, N.; Pichler, I.; Jackson, A.U.; Webster, R.J.; Zhang, F.; Peden, J.F.; Schmidt, H.; Tanaka, T.; Campbell, H.; Igl, W.; Milaneschi, Y.; Hottenga, J.-J.; Vitart, V.; Chasman, D.I.; Trompet, S.; Bragg-Gresham, J.L.; Alizadeh, B.Z.; Chambers, J.C.; Guo, X.; Lehtimaki, T.; Kuhnel, B.; Lopez, L.M.; Polasek, O.; Boban, M.; Nelson, C.P.; Morrison, A.C.; Pihur, V.; Ganesh, S.K.; Hofman, A.; Kundu, S.; Mattace-Raso, F.U.S.; Rivadeneira, F.; Sijbrands, E.J.G.; Uitterlinden, A.G.; Hwang, S.-J.; Vasan, R.S.; Wang, T.J.; Bergmann, S.; Vollenweider, P.; Waeber, G.; Laitinen, J.; Pouta, A.; Zitting, P.; McArdle, W.L.; Kroemer, H.K.; Volker, U.; Volzke, H.; Glazer, N.L.; Taylor, K.D.; Harris, T.B.; Alavere, H.; Haller, T.; Keis, A.; Tammesoo, M.-L.; Aulchenko, Y.; Barroso, I.; Khaw, K.-T.; Galan, P.; Hercberg, S.; Lathrop, M.; Eyheramendy, S.; Org, E.; Sober, S.; Lu, X.; Nolte, I.M.; Penninx, B.W.; Corre, T.; Masciullo, C.; Sala, C.; Groop, L.; Voight, B.F.; Melander, O.; O'Donnell, C.J.; Salomaa, V.; d'Adamo, A.P.; Fabretto, A.; Faletra, F.; Ulivi, S.; Del Greco M, F.; Facheris, M.; Collins, F.S.; Bergman, R.N.; Beilby, J.P.; Hung, J.; Musk, A.W.; Mangino, M.; Shin, S.-Y.; Soranzo, N.; Watkins, H.; Goel, A.; Hamsten, A.; Gider, P.; Loitfelder, M.; Zeginigg, M.; Hernandez, D.; Najjar, S.S.; Navarro, P.; Wild, S.H.; Corsi, A.M.; Singleton, A.; de Geus, E.J.C.; Willemsen, G.; Parker, A.N.; Rose, L.M.; Buckley, B.; Stott, D.; Orru, M.; Uda, M.; van der Klauw, M.M.; Zhang, W.; Li, X.; Scott, J.; Chen, Y.-D.I.; Burke, G.L.; Kahonen, M.; Viikari, J.; Doring, A.; Meitinger, T.; Davies, G.; Starr, J.M.; Emilsson, V.; Plump, A.; Lindeman, J.H.; Hoen, P.A.C.t.; Konig, I.R.; Felix, J.F.; Clarke, R.; Hopewell, J.C.; Ongen, H.; Breteler, M.; Debette, S.; DeStefano, A.L.; Fornage, M.; Mitchell, G.F.; Smith, N.L.; Holm, H.; Stefansson, K.; Thorleifsson, G.; Thorsteinsdottir, U.; Samani, N.J.; Preuss, M.; Rudan, I.; Hayward, C.; Deary, I.J.; Wichmann, H.E.; Raitakari, O.T.; Palmas, W.; Kooner, J.S.; Stolk, R.P.; Jukema, J.W.; Wright, A.F.; Boomsma, D.I.; Bandinelli, S.; Gyllensten, U.B.; Wilson, J.F.; Ferrucci, L.; Schmidt, R.; Farrall, M.; Spector, T.D.; Palmer, L.J.; Tuomilehto, J.; Pfeufer, A.; Gasparini, P.; Siscovick, D.; Altshuler, D.; Loos, R.J.F.; Toniolo, D.; Snieder, H.; Gieger, C.; Meneton, P.; Wareham, N.J.; Oostra, B.A.; Metspalu, A.; Launer, L.; Rettig, R.; Strachan, D.P.; Beckmann, J.S.; Witteman, J.C.M.; Erdmann, J.; van Dijk, K.W.; Boerwinkle, E.; Boehnke, M.; Ridker, P.M.; Jarvelin, M.-R.; Chakravarti, A.; Abecasis, G.R.; Gudnason, V.; Newton-Cheh, C.; Levy, D.; Munroe, P.B.; Psaty, B.M.; Caulfield, M.J.; Rao, D.C.; Tobin, M.D.; Elliott, P.; van Duijn, C.M. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat. Genet., 2011, 43, 1005-1011.
7. Fields, L.E.; Burt, V.L.; Cutler, J.A.; Hughes, J.; Roccella, E.J.; Sorlie, P. The burden of adult hypertension in the United States 1999 to 2000: A rising tide. Hypertension, 2004, 44, 398-404.
8. G.B., E.; Munroe, P.B.; Rice, K.M.; Bochud, M.; Johnson, A.D.; Chasman, D.I.; Smith, A.V.; Tobin, M.D.; Verwoert, G.C.; Hwang, S.-J.; Pihur, V.; Vollenweider, P.; O'Reilly, P.F.; Amin, N.; Bragg-Gresham, J.L.; Teumer, A.; Glazer, N.L.; Launer, L.; Zhao, J.H.; Aulchenko, Y.; Heath, S.; Sober, S.; Parsa, A.; Luan, J.a.; Arora, P.; Dehghan, A.; Zhang, F.; Lucas, G.; Hicks, A.A.; Jackson, A.U.; Peden, J.F.; Tanaka, T.; Wild, S.H.; Rudan, I.; Igl, W.; Milaneschi, Y.; Parker, A.N.; Fava, C.; Chambers, J.C.; Fox, E.R.; Kumari, M.; Go, M.J.; van der Harst, P.; Kao, W.H.L.; Sjogren, M.; Vinay, D.G.; Alexander, M.; Tabara, Y.; Shaw-Hawkins, S.; Whincup, P.H.; Liu, Y.; Shi, G.; Kuusisto, J.; Tayo, B.; Seielstad, M.; Sim, X.; Nguyen, K.-D.H.; Lehtimaki, T.; Matullo, G.; Wu, Y.; Gaunt, T.R.; Onland-Moret, N.C.; Cooper, M.N.; Platou, C.G.P.; Org, E.; Hardy, R.; Dahgam, S.; Palmen, J.; Vitart, V.; Braund, P.S.; Kuznetsova, T.; Uiterwaal, C.S.P.M.; Adeyemo, A.; Palmas, W.; Campbell, H.; Ludwig, B.; Tomaszewski, M.; Tzoulaki, I.; Palmer, N.D.; Palmer, N.D.; T., A.; Garcia, M.; Chang, Y.-P.C.; O'Connell, J.R.; Steinle, N.I.; Grobbee, D.E.; Arking, D.E.; Kardia, S.L.; Morrison, A.C.; Hernandez, D.; Najjar, S.; McArdle, W.L.; Hadley, D.; Brown, M.J.; Connell, J.M.; Hingorani, A.D.; Day, I.N.M.; Lawlor, D.A.; Beilby, J.P.; Lawrence, R.W.; Clarke, R.; Hopewell, J.C.; Ongen, H.; Dreisbach, A.W.; Li, Y.; Young, J.H.; Bis, J.C.; Kahonen, M.; Viikari, J.; Adair, L.S.; Lee, N.R.; Chen, M.-H.; Olden, M.; Pattaro, C.; Bolton, J.A.H.; Kottgen, A.; Bergmann, S.; Mooser, V.; Chaturvedi, N.; Frayling, T.M.; Islam, M.; Jafar, T.H.; Erdmann, J.; Kulkarni, S.R.; Bornstein, S.R.; Grassler, J.; Groop, L.; Voight, B.F.; Kettunen, J.; Howard, P.; Taylor, A.; Guarrera, S.; Ricceri, F.; Emilsson, V.; Plump, A.; Barroso, I.; Khaw, K.-T.; Weder, A.B.; Hunt, S.C.; Sun, Y.V.; Bergman, R.N.; Collins, F.S.; Bonnycastle, L.L.; Scott, L.J.; Stringham, H.M.; Peltonen, L.; Perola, M.; Vartiainen, E.; Brand, S.-M.; Staessen, J.A.; Wang, T.J.; Burton, P.R.; Soler Artigas, M.; Dong, Y.; Snieder, H.; Wang, X.; Zhu, H.; Lohman, K.K.; Rudock, M.E.; Heckbert, S.R.; Smith, N.L.; Wiggins, K.L.; Doumatey, A.; Shriner, D.; Veldre, G.; Viigimaa, M.; Kinra, S.; Prabhakaran, D.; Tripathy, V.; Langefeld, C.D.; Rosengren, A.; Thelle, D.S.; Corsi, A.M.; Singleton, A.; Forrester, T.; Hilton, G.; McKenzie, C.A.; Salako, T.; Iwai, N.; Kita, Y.; Ogihara, T.; Ohkubo, T.; Okamura, T.; Ueshima, H.; Umemura, S.; Eyheramendy, S.; Meitinger, T.; Wichmann, H.E.; Cho, Y.S.; Kim, H.-L.; Lee, J.-Y.; Scott, J.; Sehmi, J.S.; Zhang, W.; Hedblad, B.; Nilsson, P.; Smith, G.D.; Wong, A.; Narisu, N.; Stancakova, A.; Raffel, L.J.; Yao, J.; Kathiresan, S.; O'Donnell, C.J.; Schwartz, S.M.; Ikram, M.A.; Longstreth, W.T., Jr.; Mosley, T.H.; Seshadri, S.; Shrine, N.R.G.; Wain, L.V.; Morken, M.A.; Swift, A.J.; Laitinen, J.; Prokopenko, I.; Zitting, P.; Cooper, J.A.; Humphries, S.E.; Danesh, J.; Rasheed, A.; Goel, A.; Hamsten, A.; Watkins, H.; Bakker, S.J.L.; van Gilst, W.H.; Janipalli, C.S.; Mani, K.R.; Yajnik, C.S.; Hofman, A.; Mattace-Raso, F.U.S.; Oostra, B.A.; Demirkan, A.; Isaacs, A.; IRivadeneira, F.; Lakatta, E.G.; Orru, M.; Scuteri, A.; Ala-Korpela, M.; Kangas, A.J.; Leo-Pekka; Soininen, P.; Tukiainen, T.; Wurtz, P.; Ong, R.T.-H.; Dorr, M.; Kroemer, H.K.; Volker, U.; Volzke, H.; Galan, P.; Hercberg, S.; Lathrop, M.; Zelenika, D.; Deloukas, P.; Mangino, M.; Spector, T.D.; Zhai, G.; Meschia, J.F.; Nalls, M.A.; Sharma, P.; Terzic, J.; Kumar, M.V.K.; Denniff, M.; Zukowska-Szczechowska, E.; Wagenknecht, L.E.; Fowkes, F.G.R.; Charchar, F.J.; Schwarz, P.E.H.; Hayward, C.; Guo, X.; Rotimi, C.; Bots, M.L.; Brand, E.; Samani, N.J.; Polasek, O.; Talmud, P.J.; Nyberg, F.; Kuh, D.; Laan, M.; Hveem, K.; Palmer, L.J.; van der Schouw, Y.T.; Casas, J.P.; Mohlke, K.L.; Vineis, P.; Raitakari, O.; Ganesh, S.K.; Wong, T.Y.; Tai, E.S.; Cooper, R.S.; Laakso, M.; Rao, D.C.; Harris, T.B.; Morris, R.W.; Dominiczak, A.F.; Kivimaki, M.; Marmot, M.G.; Miki, T.; Saleheen, D.; Chandak, G.R.; Coresh, J.; Navis, G.; Salomaa, V.; Han, B.-G.; Zhu, X.; Kooner, J.S.; Melander, O.; Ridker, P.M.; Bandinelli, S.; Gyllensten, U.B.; Wright, A.F.; Wilson, J.F.; Ferrucci, L.; Farrall, M.; Tuomilehto, J.; Pramstaller, P.P.; Elosua, R.; Soranzo, N.; Sijbrands, E.J.G.; Altshuler, D.; Loos, R.J.F.; Shuldiner, A.R.; Gieger, C.; Meneton, P.; Uitterlinden, A.G.; Wareham, N.J.; Gudnason, V.; Rotter, J.I.; Rettig, R.; Uda, M.; Strachan, D.P.; Witteman, J.C.M.; Hartikainen, A.-L.; Beckmann, J.S.; Boerwinkle, E.; Vasan, R.S.; Boehnke, M.; Larson, M.G.; Jarvelin, M.-R.; Psaty, B.M.; Abecasis, G.R.; Chakravarti, A.; Elliott, P.; van Duijn, C.M.; Newton-Cheh, C.; Levy, D.; Caulfield, M.J.; Johnson, T. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature, 2011, 478, 103-109.
9. Bhatnagar, P.; Barron-Casella, E.; Bean, C.J.; Milton, J.N.; Baldwin, C.T.; Steinberg, M.H.; DeBaun, M.; Casella, J.F.; Arking, D.E. Genome-Wide Meta-Analysis of Systolic Blood Pressure in Children with Sickle Cell Disease. PLoS ONE, 2013, 8, e74193.
10. Niu, Y.; Gong, Y.; Langaee, T.Y.; Davis, H.M.; Elewa, H.; Beitelshees, A.L.; Moss, J.I.; Cooper-DeHoff, R.M.; Pepine, C.J.; Johnson, J.A. Genetic Variation in the β2 Subunit of the Voltage-Gated Calcium Channel and Pharmacogenetic Association With Adverse Cardiovascular Outcomes in the INternational VErapamil SRTrandolapril STudy GENEtic Substudy (INVEST-GENES). Circ. Cardiovasc. Genet., 2010, 3, 548-555.
11. Lin, Y.; Lai, X.; Chen, B.; Xu, Y.; Huang, B.; Chen, Z.; Zhu, S.; Yao, J.; Jiang, Q.; Huang, H.; Wen, J.; Chen, G. Genetic variations in CYP17A1, CACNB2 and PLEKHA7 are associated with blood pressure and/or hypertension in she ethnic minority of China. Atherosclerosis, 2011, 219, 709-714.
12. Smoller, J.W.; Kendler, K.; Craddock, N.; Lee, P.H.; Neale, B.M.; Nurnberger, J.I.; Ripke, S.; Santangelo, S.; Sullivan, P.F.; Purcell, S.; Anney, R.; Buitelaar, J.; Fanous, A.; Faraone, S.V.; Hoogendijk, W.; Lesch, K.-P.; Levinson, D.F.; Perlis, R.H.; Rietschel, M.; Riley, B.; Sonuga-Barke, E.; Schachar, R.; Schulze, T.G.; Thapar, A.; Neale, M.; Bender, P.; Cichon, S.; Daly, M.J.; Kelsoe, J.; Lehner, T.; O'Donovan, M.; Gejman, P.; Sebat, J.; Sklar, P.; Devlin, B. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet, 2013, 381, 1371-1379.
13. Lee, M.T.M.; Chen, C.H.; Lee, C.S.; Chen, C.C.; Chong, M.Y.; Ouyang, W.C.; Chiu, N.Y.; Chuo, L.J.; Chen, C.Y.; Tan, H.K.L.; Lane, H.Y.; Chang, T.J.; Lin, C.H.; Jou, S.H.; Hou, Y.M.; Feng, J.; Lai, T.J.; Tung, C.L.; Chen, T.J.; Chang, C.J.; Lung, F.W.; Chen, C.K.; Shiah, I.S.; Liu, C.Y.; Teng, P.R.; Chen, K.H.; Shen, L.J.; Cheng, C.S.; Chang, T.P.; Li, C.F.; Chou, C.H.; Chen, C.Y.; Wang, K.H.T.; Fann, C.S.J.; Wu, J.Y.; Chen, Y.T.; Cheng, A.T.A. Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol. Psychiatry, 2011, 16, 548-556.
14. Jan, W.-C.; Yang, S.-Y.; Chuang, L.-C.; Lu, R.-B.; Lu, M.-K.; Sun, H.S.; Kuo, P.-H. Exploring the associations between genetic variants in genes encoding for subunits of calcium channel and subtypes of bipolar disorder. J. Affect. Disord., 2014, 157, 80-86.
15. Foell, J.D.; Balijepalli, R.C.; Delisle, B.P.; Yunker, A.M.R.; Robia, S.L.; Walker, J.W.; McEnery, M.W.; January, C.T.; Kamp, T.J. Molecular heterogeneity of calcium channel β-subunits in canine and human heart: evidence for differential subcellular localization. Physiol. Genomics, 2004, 17, 183-200.
16. Polimanti, R.; Iorio, A.; Piacentini, S.; Manfellotto, D.; Fuciarelli, M. Human pharmacogenomic variation of antihypertensive drugs: from population genetics to personalized medicine. Pharmacogenomics, 2014, 15, 157-167.
17. Tomaselli, G.F.; Marban, E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc., Res. 1999, 42, 270-283.
18. Ca2+ channels leads to single-channel activity characteristic of heart failure. PLoS ONE, 2007, 2, e292.
19. Ca2+-channels: implications for fibrosis and heart rate in mice. Cardiovasc. Res., 2009, 84, 396-406.
20. Antzelevitch, C.; Pollevick, G.D.; Cordeiro, J.M.; Casis, O.; Sanguinetti, M.C.; Aizawa, Y.; Guerchicoff, A.; Pfeiffer, R.; Oliva, A.; Wollnik, B.; Gelber, P.; Bonaros, E.P., Jr.; Burashnikov, E.; Wu, Y.; Sargent, J.D.; Schickel, S.; Oberheiden, R.; Bhatia, A.; Hsu, L.-F.; Haissaguerre, M.; Schimpf, R.; Borggrefe, M.; Wolpert, C. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation, 2007, 115, 442-449.
21. Hedley, P.L.; Jørgensen, P.; Schlamowitz, S.; Moolman-Smook, J.; Kanters, J.K.; Corfield, V.A.; Christiansen, M. The genetic basis of Brugada syndrome: A mutation update. Hum. Mutation, 2009, 30, 1256-1266.
22. Burashnikov, E.; Pfeiffer, R.; Barajas-Martinez, H.; Delpon, E.; Hu, D.; Desai, M.; Borggrefe, M.; Haissaguerre, M.; Kanter, R.; Pollevick, G.D.; Guerchicoff, A.; Laino, R.; Marieb, M.; Nademanee, K.; Nam, G.-B.; Robles, R.; Schimpf, R.; Stapleton, D.D.; Viskin, S.; Winters, S.; Wolpert, C.; Zimmern, S.; Veltmann, C.; Antzelevitch, C. Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm, 2010, 7, 1872-1882.
23. Hu, D.A.N.; Barajas-Martinez, H.; Nesterenko, V.V.; Pfeiffer, R.; Guerchicoff, A.; Cordeiro, J.M.; Curtis, A.B.; Pollevick, G.D.; Wu, Y.; Burashnikov, E.; Antzelevitch, C. Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome. Pacing Clin. Electrophysiol., 2010, 33, 274-285.
24. Bhat, S.; Dao, D.T.; Terrillion, C.E.; Arad, M.; Smith, R.J.; Soldatov, N.M.; Gould, T.D. CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog. Neurobiol., 2012, 99, 1-14.
25. Juraeva, D.; Haenisch, B.; Zapatka, M.; Frank, J.; Witt, S.H.; Muhleisen, T.W.; Treutlein, J.; Strohmaier, J.; Meier, S.; Degenhardt, F.; Giegling, I.; Ripke, S.; Leber, M.; Lange, C.; Schulze, T.G.; Mossner, R.; Nenadic, I.; Sauer, H.; Rujescu, D.; Maier, W.; Børglum, A.; Ophoff, R.; Cichon, S.; Nothen, M.M.; Rietschel, M.; Mattheisen, M.; Brors, B. Integrated Pathway-Based Approach Identifies Association between Genomic Regions at CTCF and CACNB2 and Schizophrenia. PLoS Genet, 2014, 10, e1004345.
26. Bers, D.M. Cardiac excitation-contraction coupling. Nature, 2002, 415, 198-205.
27. Kobrinsky, E.; Duong, S.Q.; Sheydina, A.; Soldatov, N.M. Microdomain organization and frequency-dependence of CREBdependent transcriptional signaling in heart cells. FASEB J., 2011, 25, 1544-1555.
28. Ca2+ signal transduction. Trends Pharm. Sci., 2003, 24, 167-171.
29. Kobrinsky, E.; Abrahimi, P.; Duong, S.Q.; Thomas, S.; Harry, J.B.; Patel, C.; Lao, Q.Z.; Soldatov, N.M. Effect of Cavβ subunits on structural organization of Cav1.2 calcium channels. PLoS ONE, 2009, 4, e5587.
30. Lipscombe, D.; Madison, D.V.; Poenie, M.; Reuter, H.; Tsien, R.Y.; Tsien, R.W. Spatial distribution of calcium channels and cytosolic calcium transients in growth cones and cell bodies of sympathetic neurons. Proc. Natl. Acad. Sci. USA, 1988, 85, 2398-2402.
31. Ca2+ channels. Proc. Natl. Acad. Sci. USA, 2005, 102, 11112-11117.
32. Ca2+ channel. Genomics, 1994, 22, 77-87.
33. Tiwari, S.; Zhang, Y.; Heller, J.; Abernethy, D.R.; Soldatov, N.M. Atherosclerosis-related molecular alteration of the human Cav1.2 calcium channel α1C subunit. Proc. Natl. Acad. Sci. USA, 2006, 103, 17024-17029.
34. Klugbauer, N.; Marais, E.; Hofmann, F. Calcium channel α2δ subunits: Differential expression, function, and drug binding. J. Bioenerg. Biomembr., 2003, 35, 639-647.
35. Dolphin, A.C. Calcium channel diversity: multiple roles of calcium channel subunits. Curr. Opin. Neurobiol., 2009, 19, 237-244.
36. Harry, J.B.; Kobrinsky, E.; Abernethy, D.R.; Soldatov, N.M. New short splice variants of the human cardiac Cavβ2 subunit: Redefining the major functional motifs implemented in modulation of the Cav1.2 channel. J. Biol. Chem., 2004, 279, 46367-46372.
37. 2 subunit splice variants on Ltype calcium channel gating. Biophys. J., 2003, 84, 3007-3021.
38. Dolphin, A.C. β Subunits of voltage-gated calcium channels. J. Bioenerg. Biomembr., 2003, 35, 599-620.
39. Ca2+ channel β subunits revealed by their expression in adult rat heart cells. J. Physiol., 2002, 541, 435-452.
40. Serikov, V.; Bodi, I.; Koch, S.E.; Muth, J.N.; Mikala, G.; Martinov, S.G.; Haase, H.; Schwartz, A. Mice with cardiac-specific sequestration of the β-subunit of the L-type calcium channel. Biochem. Biophys. Res. Commun., 2002, 293, 1405-1411.
41. Haase, H.; Kresse, A.; Hohaus, A.; Schulte, H.D.; Maier, M.; Osterziel, K.J.; Lange, P.E.; Morano, I. Expression of calcium channel subunits in the normal and diseased human myocardium. J. Mol. Med., 1996, 74, 99-104.
42. 1b-subunit by sizeexclusion chromatography and its role on channel function. J. Biol. Chem., 2004, 279, 21689-21694.
43. Ca2+ channel activity. FASEB J., 2010, 24, 5024-5032.
44. Tareilus, E.; Roux, M.; Qin, N.; Olcese, R.; Zhou, J.; Stefani, E.; Birnbaumer, L. A Xenopus oocyte β subunit: Evidence for a role in the assembly/expression of voltage-gated calcium channels that is separate from its role as a regulatory subunit. Proc. Natl. Acad. Sci. USA, 1997, 94, 1703-1708.
45. Collin, T.; Wang, J.J.; Nargeot, J.; Schwartz, A. Molecular cloning of three isoforms of the L-type voltage-dependent calcium channel beta subunit from normal human heart. Circ. Res., 1993, 72, 1337-1344.
46. Hullin, R.; Asmus, F.; Ludwig, A.; Hersel, J.; Boekstegers, P. Subunit expression of the cardiac L-type calcium channel is differentially regulated in diastolic heart failure of the cardiac allograft. Circulation, 1999, 100, 155-163.
47. Collin, T.; Lory, P.; Taviaux, S.; Courtieu, C.; Guilbault, P.; Berta, P.; Nargeot, J. Cloning, chromosomal location and functional expression of the human voltage-dependent calcium-channel β3 subunit. Eur. J. Biochem., 1994, 220, 257-262.
48. Ca2+ channel β3 subunit. J. Biol. Chem., 2003, 278, 43261-43267.
49. Castellano, A.; Wei, X.; Birnbaumer, L.; Perez-Reyes, E. Cloning and expression of a third calcium channel β subunit. J. Biol. Chem., 1993, 268, 3450-3455.
50. Hullin, R.; Singer-Lahat, D.; Freichel, M.; Biel, M.; Dascal, N.; Hofmann, F.; Flockerzi, V. Calcium channel β subunit heterogeneity: Functional expression of cloned cDNA from heart, aorta and brain. EMBO J., 1992, 11, 885-890.
51. Lie, A.A.; Blumcke, I.; Volsen, S.G.; Wiestler, O.D.; Elger, C.E.; Beck, H. Distribution of voltage-dependent calcium channel beta subunits in the hippocampus of patients with temporal lobe epilepsy. Neuroscience, 1999, 93, 449.
52. Birnbaumer, L.; Qin, N.; Olcese, R.; Tareilus, E.; Platano, D.; Costantin, J.; Stefani, E. Structures and functions of calcium channel beta subunits. J. Bioenerg. Biomembr., 1998, 30, 357-75.
53. Hullin, R.; Khan, I.F.Y.; Wirtz, S.; Mohacsi, P.; Varadi, G.; Schwartz, A.; Herzig, S. Cardiac L-type calcium channel β-subunits expressed in human heart have differential effects on single channel characteristics. J. Biol. Chem., 2003, 278, 21623-21630.
54. 1C subunit. J. Biol. Chem., 1998, 273, 19348-19356.
55. Ca2+ channels of skeletal muscle. J. Physiol., 2002, 545, 407-419.
56. 1-subunit. Nature, 1994, 368, 67-70.
57. 2 subunit modulation of the Cav1.2 calcium channel. J. Biol. Chem., 2008, 283, 15577-15588.
58. Ca2+ channels. Physiol. Rev., 2010, 90, 1461-1506.
59. Maltez, J.M.; Nunziato, D.A.; Kim, J.; Pitt, G.S. Essential Cavβ modulatory properties are AID-independent. Nat. Struct. Mol. Biol., 2005, 12, 372-377.
60. Berjukow, S.; Doring, F.; Froschmayr, M.; Grabner, M.; Glossmann, H.; Hering, S. Endogenous calcium channels in human embryonic kidney (HEK293) cells. Br. J. Pharmacol., 1996, 118, 748-754.
61. Kurejova, M.; Uhrik, B.; Sulová, Z.; Sedláková, B.; Križanova, O.; Lacinova, L. Changes in ultrastructure and endogenous ionic channels activity during culture of HEK 293 cell line. Eur. J. Pharmacol. 2007, 567, 10-18.
62. Ravindran, A.; Lao, Q.Z.; Harry, J.B.; Abrahimi, P.; Kobrinsky, E.; Soldatov, N.M. Calmodulin-dependent gating of Cav1.2 calcium channels in the absence of Cavβ subunits. Proc. Natl. Acad. Sci. USA, 2008, 105, 8154-8159.
63. Ca2+ channels by calmodulin. Sci. STKE, 2005, 2005, re15.
64. Dolmetsch, R.E.; Pajvani, U.; Fife, K.; Spotts, J.M.; Greenberg, M.E. Signaling to the nucleus by an L-type calcium channelcalmodulin complex through the MAP kinase pathway. Science, 2001, 294, 333-339.
65. Ca2+ channel cytoplasmic tails and its regulatory role. J. Biol. Chem., 2003, 278, 5021-5028.
66. Ca2+ channel inactivation. Biophys. J., 2004, 87, 844-857.
67. Tsien, R.Y. Unlocking cell secrets with light beams and molecular spies; Amsterdam, 2002.
68. Ca2+ channel and its modulation by protein kinase C. J. Biol. Chem., 1998, 273, 17901-17909.
69. 1C subunit. Receptors Channels, 1996, 4, 205-15.
70. Ca2+ ions. J. Biol. Chem., 2005, 280, 12474-12485.
71. 1C (Cav1.2α). J. Gen. Physiol., 2006, 128, 15-36.
72. 1C. J. Biol. Chem., 2000, 275, 39846-39854.
73. Ca2+ channel modulation by recombinant auxiliary β subunits expressed in young adult heart cells. Circ. Res., 2000, 86, 175-184.
74. α2-subunit and the associated δ peptides. J. Biol. Chem., 1991, 266, 3287-3293.
75. Ca2+ channel complex purified from brain. Science, 1993, 261, 486-489.
76. Ca2+ channels during hypertension and Timothy syndrome. Circ. Res., 2010, 106, 748-756.
77. Abernethy, D.R.; Schwartz, J.B. Calcium-antagonist drugs. N. Engl. J. Med., 1999, 341, 1447-1457.
78. Ca2+ channels in cardiac cells. J. Pharmacol. Exp. Ther., 2008, 325, 37-46.
79. Sonkusare, S.; Fraer, M.; Marsh, J.D.; Rusch, N.J. Disrupting calcium channel expression to lower blood pressure: New targeting of a well-known channel. Mol. Interv., 2006, 6, 304-310.
80. Bannister, J.P.; Adebiyi, A.; Zhao, G.; Narayanan, D.; Thomas, C.M.; Feng, J.Y.; Jaggar, J.H. Smooth muscle cell α2δ-1 subunits are essential for vasoregulation by Cav1.2 channels. Circ. Res. 2009, 105, 948-955.
81. Meissner, M.; Weissgerber, P.; Londono, J.E.C.; Prenen, J.; Link, S.; Ruppenthal, S.; Molkentin, J.D.; Lipp, P.; Nilius, B.; Freichel, M.; Flockerzi, V. Moderate calcium channel dysfunction in adult mice with inducible cardiomyocyte-specific excision of the cacnb2 gene. J. Biol. Chem., 2011, 286, 15875-15882.